An experimental Ebola vaccine which has been made by GlaxoSmithKline resulted in no serious side effects turned out to produce an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial according to scientists reported the New England Journal of Medicine. Continue Reading
